These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 10770751

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics and safety of trovafloxacin in healthy male volunteers following administration of single intravenous doses of the prodrug, alatrofloxacin.
    Vincent J, Venitz J, Teng R, Baris BA, Willavize SA, Polzer RJ, Friedman HL.
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():75-80. PubMed ID: 9222074
    [Abstract] [Full Text] [Related]

  • 3. Single- and multiple-dose administration, dosing regimens, and pharmacokinetics of trovafloxacin and alatrofloxacin in humans.
    Vincent J, Dogolo L, Baris BA, Willavize SA, Teng R.
    Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):427-30. PubMed ID: 9758287
    [Abstract] [Full Text] [Related]

  • 4. Concentrations of trovafloxacin in colonic tissue and peritoneal fluid after intravenous infusion of the prodrug alatrofloxacin in patients undergoing colorectal surgery.
    Melnik G, Schwesinger WH, Dogolo LC, Teng R, Vincent J.
    Am J Surg; 1998 Dec; 176(6A Suppl):14S-17S. PubMed ID: 9935251
    [Abstract] [Full Text] [Related]

  • 5. Safety and tolerability of intravenous-to-oral treatment and single-dose intravenous or oral prophylaxis with trovafloxacin.
    Williams DJ, Hopkins S.
    Am J Surg; 1998 Dec; 176(6A Suppl):74S-79S. PubMed ID: 9935261
    [Abstract] [Full Text] [Related]

  • 6. Penetration of trovafloxacin into cerebrospinal fluid in humans following intravenous infusion of alatrofloxacin.
    Cutler NR, Vincent J, Jhee SS, Teng R, Wardle T, Lucas G, Dogolo LC, Sramek JJ.
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1298-300. PubMed ID: 9174187
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Oral bioavailability of trovafloxacin with and without food in healthy volunteers.
    Teng R, Dogolo LC, Willavize SA, Friedman HL, Vincent J.
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():87-92. PubMed ID: 9222076
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics and metabolism of single oral doses of trovafloxacin.
    Vincent J, Teng R, Dalvie DK, Friedman HL.
    Am J Surg; 1998 Dec; 176(6A Suppl):8S-13S. PubMed ID: 9935250
    [Abstract] [Full Text] [Related]

  • 11. Activity of trovafloxacin (CP-99,219) against Legionella isolates: in vitro activity, intracellular accumulation and killing in macrophages, and pharmacokinetics and treatment of guinea pigs with L. pneumophila pneumonia.
    Edelstein PH, Edelstein MA, Ren J, Polzer R, Gladue RP.
    Antimicrob Agents Chemother; 1996 Feb; 40(2):314-19. PubMed ID: 8834872
    [Abstract] [Full Text] [Related]

  • 12. Trovafloxacin in the treatment of intra-abdominal infections: results of a double-blind, multicenter comparison with imipenem/cilastatin. Trovafloxacin Surgical Group.
    Donahue PE, Smith DL, Yellin AE, Mintz SJ, Bur F, Luke DR.
    Am J Surg; 1998 Dec; 176(6A Suppl):53S-61S. PubMed ID: 9935258
    [Abstract] [Full Text] [Related]

  • 13. Multiple-dose pharmacokinetics and safety of trovafloxacin in healthy volunteers.
    Teng R, Liston TE, Harris SC.
    J Antimicrob Chemother; 1996 May; 37(5):955-63. PubMed ID: 8737145
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Levofloxacin and trovafloxacin: the next generation of fluoroquinolones?
    Ernst ME, Ernst EJ, Klepser ME.
    Am J Health Syst Pharm; 1997 Nov 15; 54(22):2569-84. PubMed ID: 9397218
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of trovafloxacin (CP-99,219), a new quinolone, in rats, dogs, and monkeys.
    Teng R, Girard D, Gootz TD, Foulds G, Liston TE.
    Antimicrob Agents Chemother; 1996 Mar 15; 40(3):561-6. PubMed ID: 8851571
    [Abstract] [Full Text] [Related]

  • 17. An open, controlled, crossover study on the effects of cimetidine on the steady-state pharmacokinetics of trovafloxacin.
    Purkins L, Oliver SD, Willavize SA.
    Eur J Clin Microbiol Infect Dis; 1998 Jun 15; 17(6):431-3. PubMed ID: 9758288
    [Abstract] [Full Text] [Related]

  • 18. Hepatobiliary elimination of trovafloxacin and metabolites following single oral doses in healthy volunteers.
    Melnik G, Schwesinger WH, Teng R, Dogolo LC, Vincent J.
    Eur J Clin Microbiol Infect Dis; 1998 Jun 15; 17(6):424-6. PubMed ID: 9758286
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics and safety of trovafloxacin (CP-99,219), a new quinolone antibiotic, following administration of single oral doses to healthy male volunteers.
    Teng R, Harris SC, Nix DE, Schentag JJ, Foulds G, Liston TE.
    J Antimicrob Chemother; 1995 Aug 15; 36(2):385-94. PubMed ID: 8522468
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics and penetration into inflammatory fluid of trovafloxacin (CP-99,219).
    Wise R, Mortiboy D, Child J, Andrews JM.
    Antimicrob Agents Chemother; 1996 Jan 15; 40(1):47-9. PubMed ID: 8787877
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.